Home›Clinical trials›Connecticut

GLP-1 clinical trials in Connecticut: 14 recruiting now

17 sites in 6 Connecticut cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (5)

Weight-loss study of orforglipron

Where: Stamford

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.

Free to join

Who can join: Children and teens 12 to 17 with obesity.

Study record on ClinicalTrials.gov

Stamford Therapeutics Consortium, Stamford

Show 2 more studies

Weight-loss study of LY3305677

Where: Stamford

What: Tests whether an investigational medicine from Lilly, LY3305677, can help people lose weight.

Free to join

Who can join: Adults 18 to 75 with obesity, BMI 27+.

Study record on ClinicalTrials.gov

Stamford Therapeutics Consortium, Stamford

Weight-loss study of olatorepatide

Where: Waterbury

What: Tests whether a GLP-1 and GIP medicine from Regeneron Pharmaceuticals, olatorepatide, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity or overweight, BMI 27+.

Study record on ClinicalTrials.gov

Chase Medical Research, Waterbury

Type 2 diabetes studies (3)

Type 2 diabetes study of cagrisema

Where: New Haven

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Children and teens 10 to 18 with type 2 diabetes.

Study record on ClinicalTrials.gov

Yale School of Medicine, New Haven

Type 2 diabetes study of semaglutide

Where: Bridgeport

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Bridgeport

Type 2 diabetes study of cagrisema

Where: Waterbury

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 25+.

Study record on ClinicalTrials.gov

Chase Medical Research LLC, Waterbury

Other GLP-1 studies in Connecticut (6)

Fatty liver disease with liver scarring study of survodutide

Where: Bristol and New Haven

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Connecticut Gastroenterology Clinical Research Foundation, Bristol. 833-602-2368

Yale University School of Medicine, New Haven. 833-602-2368

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Bristol

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Connecticut Gastroenterology Clinical Research Foundation, Bristol. 833-602-2368

Show 3 more studies

Fatty liver disease (MASLD) study of retatrutide

Where: Hamden

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Study record on ClinicalTrials.gov

Medical Research Center of Connecticut, Hamden

Type 1 diabetes study of semaglutide

Where: New Haven

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 1 diabetes lower blood sugar and lose weight.

Free to join

Who can join: Adults 18 to 30 with type 1 diabetes, BMI 27+.

Study record on ClinicalTrials.gov

Yale Pediatric Diabetes Center, Adult and Children's Progam, New Haven

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

Written and edited by GLP ChartAbout this siteContact
Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.